Table of Contents

    Topic review

    Milk Thistle Seed and Hempseed

    Submitted by: Ondřej Šťastník


    In accordance with Commission Regulation (EC) No 726/2004, the use of antibiotics as stimulators of animal growth and performance has been banned in all European Union countries since 2006 (due to the elimination of antibiotic residues from the human food chain). Due to this ban, many scientists are studying alternative approaches to the use of various biologically active substances with a growth-promoting e ect. A promising direction is the use of alternative feeds containing bioactive compounds or mixtures of natural origin, or the use of phytoadditives or plant extracts, probiotics, prebiotics, symbiotics or oilseed by-products, such as hempseed cakes and milk thistle seed cakes in animal nutrition.

    1. Introduction

    1.1. Silybum marianum (L.)

    Milk thistle (Silybum marianum L.) is an annual or biennial herb naturally occurring in the regions of the Mediterranean and North Africa [1]. The active substances contained in the purple variety of milk thistle, known as the silymarin complex, have hepatoprotective, detoxifying and antioxidant effects, thanks to which parts of this plant are used for the treatment and prevention of liver and bile diseases (hepatitis, cirrhosis) and hence the protection from toxins and various chemicals substances [2].

    The highest proportion of active substances of the silymarin complex is found in the seeds, which contain about 70–80% of the silymarin flavonolignans and about 20–30% of chemically undefined substances mainly of the polyphenol structure [2]. According to Kroll et al. [3] the silymarin complex is composed of at least seven flavonolignans and one flavonoid (taxifolin). Milk thistle seeds also contain betaine, trimethyl glycine and essential fatty acids involved in the hepatoprotective and anti-inflammatory effects of the silymarin complex [4][5].

    Milk thistle seeds contain 23% ether extract: Oil obtained is a rich source of tocopherols and fatty acids. Milk thistle oil contains 27–64% linoleic acid (C18:2, n-6), 21–50% is oleic acid (C18:1, n-9), 7–14% palmitic acid (C16: 0) and 2–6% stearic acid (C18:0), and α-linolenic acid (C18:3, n-3) is contained in milk thistle seed oil in an amount of 5% [6].

    1.2. Cannabis sativa (L.)

    Hemp (Cannabis sativa L.) is an annual, up to 2 m tall plant with palm split leaves and multi-sex flowers [7]. Generally, fruits (hempseeds) contain about 25% crude protein, 30% ether extract. The gross energy content of cannabis seeds is 22 MJ/kg [8]. Unhulled hemp seeds contain 25–34% fat and dehulled seeds contain 42–47% fat. Hemp oil, obtained after the pressing of seeds, consists of 75–80% polyunsaturated fatty acids (PUFAs), of which 53–60% is linoleic acid (C18:2, n-6), 15–25% α-linolenic acid (C18:3, n-3) and 3–6% γ-linolenic acid (C18:3, n-6). Oleic acid (C18:1, n-9) contains hemp oil 8–15%. Hemp seed oil is also a rich source of tocopherols, which contains 1500 mg per kilogram [8][9]. The two major proteins present (edestin and albumin) are easily digestible and contain all essential amino acids [8][10]. In regards to protein quality, lysine is the first limiting amino acid in cannabis protein for several animals [11].

    In addition to these essential nutrients, cannabis contains compounds such as plant sterols and phytocannabinoids, including the most abundant delta-9-tetrahydrocannabinol (THC), which is a strong fat-soluble antioxidant, stimulating appetite [12][13][14]. Cannabinoids are substances found only in cannabis. Cannabis contains more than 60 (phyto) cannabinoids that have anti-inflammatory, analgesic effects [15][16][17] , anti-ischemic [18], antipsychotic, anxiolytic (against anxiety) [19] and effects against epilepsy [20]. Antimicrobial, immunomodulatory, antioxidant and antihypertensive effects are also described [14].

    The best known and most studied of the cannabinoids is psychoactive tetrahydrocannabinol (THC), whose metabolite with potential immunosuppressive and anti-inflammatory effects that retains its psychoactive effects is cannabinol (CBN). Another metabolite of THC is the so-called cannabidiol (CBD), which no longer has psychoactive effects[21]. Other cannabinoids studied include dronabinol (DBN), nabilone, CBN, CBD, and cannabichromen (CBC) and cannabigerol (CBG). Cannabis cultivated in temperate climates contains less psychoactive cannabinoid THC, it also contains less of the second most common CBD that has no psychoactive effects[21]. The nutrient composition, and hence the composition of the cannabis ingredients and by-products, can vary considerably (Figure 1).

    Milk thistle seed (left) and hemp seed (right)

    Figure 1. Milk Thistle Seed and Hempseed

    2. The Milk Thistle Seed and Hemp Seed Bioactive Substances Effects on Animals Metabolism and Performance

    Many authors have tried to make milk thistle substances available to poultry without the need to feed expellers or other forms of plant by-products [22][23][24]. For example, Gawel et al. [24] fed chickens and turkeys with a commercial preparation containing 80% of silymarin at doses of 0.5 kg and 1 kg per ton of feed mixture. These authors found that the final live weight of the Cobb 500 chickens in the experimental groups was 4.8–6.6% higher than in the control group. Feed conversion ratio was balanced in all groups. The authors recorded the highest percentage of mortality (4.1%) in the chickens of the control group. Similarly, these authors Gawel et al. [24] found 1.9–3.8% higher live weight in BUT 9 hybrid turkeys fed mixtures containing the addition of silymarin compared to the control group. The turkeys were similarly affected, with a higher live weight of 2.5–3.0%. Schiavone et al. [22] found no differences in the live weight of chickens at the end of the experiment, but also in feed consumption and feed conversion when feeding a commercial milk thistle seed extract containing 40 and 80 ppm of silymarin. Another study by Zarei et al. [23] applied 1 mL of milk thistle extract in ovo in two dilutions (100 and 200 mg/L) and then also added it to the feed mixture at a dose of 100 mg/kg. They found that the level of 100 mg/L in ovo caused a significantly lower (p < 0.05) chicken’s final live weight (2125 g) at 42 days of age compared to the control group (2179 g). The feed mixture containing 100 mg/kg of extract caused significantly higher final live weight (2218 g) of chickens compared to the control group (2079 g). Silymarin also has a positive effect on feed intake, weight gain [25][26][27][28][29] and liver tissue morphology of chickens [27]. In addition, silymarin supplementation has a significant effect on meat quality and shelf life by increasing post-mortem oxidative stability [22].

    The enzymes GGT and AST are considered physiological indicators of liver health. High gamma-glutamyl transferase enzyme activity in avian blood plasma is associated with hyperplasia and bile duct tumors [30]. It was claimed by Tedesco et al. [25] that silymarin content of 600 mg/kg in the diet can reduce the plasma GGT and AST activity in broiler chickens’ blood affected by aflatoxicosis. In addition, silymarin has been shown to reduce the activity of these enzymes in people with liver diseases [31] as well. In [32], significantly lowered activity of ALT and AST enzymes in the blood plasma of the experimental groups (0.2% and 1% of milk thistle seed cakes in the diets) was found, compared to the control group, on day 22 of the chicken fattening period. At day 43 of fattening, the lower activity of these enzymes in the experimental groups was not conclusive, but lower GGT enzyme activity and lower cholesterol levels were demonstrated in the group containing 1% seed cakes in the diet compared to the control group [32]. Similar results were achieved by Alassi and Allaw [33] with the addition 1 g/kg milk thistle seed powder in quail diet. A significantly lower level of cholesterol, glutathione (GSH), malondialdehyde (MDA), ALT and AST and a higher level glucose, total protein and globulin was found in the experimental group compared to the control group. Moreover, after the addition of 150 g/day of milk thistle seed cakes to dairy cattle [34], a higher AST enzyme activity was found, with other measured parameters GGT, LD, total protein, albumin, glucose, unesterified fatty acids, β-hydroxybutyrate, urea and bilirubin unchanged. In contrast to the above authors, our results in the inclusion of milk thistle seed cakes in the poultry diet did not affect the activity of liver-specific enzymes such as AST and GGT [35].

    The entry is from 10.3390/ani10081384


    1. Khan, M.A.; Blackshaw, R.E.; Marwat, K.B. Biology of milk thistle (Silybum marianum) and the management options for growers in north-western Pakistan. Weed Biol. Manag. 2009, 9, 99–105.
    2. Křen, V.; Walterová, D. Silybin and silymarin—New effects and applications. Biomed. Pap. 2005, 149, 29–41.
    3. Kroll, D.J.; Shaw, H.S.; Oberlies, N.H. Milk thistle nomenclature: Why it matters in cancer research and pharmacokinetic studies. Integr. Cancer 2007, 6, 110–119.
    4. Luper, S. A review of plants used in the treatment of liver disease: Part 1. Altern. Med. Rev. 1998, 3, 410–421.
    5. Saller, R.; Meier, R.; Brignoli, R. The use of silymarin in the treatment of liver diseases. Drugs 2001, 61, 2035–2063.
    6. Chambers, C.S.; Holečková, V.; Petrásková, L.; Biedermann, D.; Valentová, K.; Buchta, M.; Křen, V. The silymarin composition and why does it matter. Food Res. Int. 2017, 100, 339–353.
    7. Padua, L.S.; Bunyaprafatsara, N.; Lemmens, R.H.M.J. Medicinal and poisonous plants. In Plant Resources of South-East Asia; Valkenburg, J.L.C.H., Bunyapraphatsara, M., Eds.; Backhuys Publishers: New Delhi, India, 1999; pp. 167–175.
    8. Callaway, J.C. Hempseed as a nutritional resource: An overview. Euphytica 2004, 140, 65–72.
    9. Gunstone, F.D.; Harwood, J.L. Occurence and characterisation of oils and fats. In The Lipid Handbook with CD-Rom.; Gunstone, F.D., Harwood, J.L., Dijkstra, A.J., Eds.; CRC Press: Boca Raton, FL, USA, 2007; pp. 37–141.
    10. Leizer, C.; Ribnicky, D.; Poulev, A.; Dushenkov, S.; Raskin, I. The composition of hempseed oil and its potential as an important source of nutrition. J. Nutraceuticals Funct. Med. Foods 2000, 2, 35–53.
    11. House, J.D.; Neufeld, J.; Leson, G. Evaluating the quality of protein from hemp seed and hemp seed products through the use of the protein digestibility-corrected amino acid score method. J. Agric. Food Chem. 2010, 58, 11801–11807.
    12. Hampson, A.J.; Grimaldi, M.; Lolic, M.; Wink, D.; Rosenthal, R.; Axelrod, J. Neuroprotective antioxidants from marijuana. Ann. NY Acad. Sci. 2000, 899, 274–282.
    13. Koch, J.E. Delta 9-THC stimulates food intake in Lewis rats: Effects on chow, high-fat and sweet high-fat diets. Pharm. Biochem. Behav. 2001, 68, 539–543.
    14. Potter, D.J.; Clark, P.; Brown, M.B. Potency of Δ9–THC and other cannabinoids in cannabis in England in 2005: Implications for psychoactivity and pharmacology. J. Forensic Sci. 2008, 53, 90–94.
    15. Hohmann, A.G.; Suplita, R.L. Endocannabinoid mechanisms of pain modulation. Aaps. J. 2006, 8, 693–708.
    16. Rea, K.; Roche, M.; Finn, D.P. Supraspinal modulation of pain by cannabinoids: The role of GABA and glutamate. Br. J. Pharm. 2007, 152, 633–648.
    17. Jhaveri, M.D.; Elmes, S.J.R.; Richardson, D.; Barrett, D.A.; Kendall, D.A.; Mason, R.; Chapman, V. Evidence for a novel functional role of cannabinoid CB2 receptors in the thalamus of neuropathic rats. Eur. J. Neurosci. 2008, 27, 1722–1730.
    18. Lamontagne, D.; Lepicier, P.; Lagneux, C.; Bouchard, J.F. The endogenous cardiac cannabinoid system: A new protective mechanism. Arch. Mal. Coeur Vaiss. 2006, 99, 242–246.
    19. Crippa, J.A.S.; Derenusson, G.N.; Ferrari, T.B.; Wichertana, L.; Duran, F.L.; Martin-Santos, R.; Filho, A.S. Neural basis of anxiolytic effects of cannabidiol (CBD) in generalized social anxiety disorder: A preliminary report. J. Psychopharmacol. 2011, 25, 121–130.
    20. Mortati, K.; Dworetzky, B.; Devinsky, O. Marijuana: An effective antiepileptic treatment in partial epilepsy? A case report and review of the literature. Rev. Neurol. Dis. 2007, 4, 103–106.
    21. Alvarado, R.I.N.; Sánchez, R.M.; Del, C.; Salcedo, V.V. Therapeutic properties of cannabinoid drugs and marijuana in several disorders: A narrative review. Salud. Ment. 2017, 40, 111–118.
    22. Schiavone, A.; Righi, F.; Quarantelli, A.; Bruni, R.; Serventi, P.; Fusari, A. Use of Silybum marianum fruit extract in broiler chicken nutrition: Influence on performance and meat quality. J. Anim. Physiol. Nutr. 2007, 91, 256–262.
    23. Zarei, A.; Morovat, M.; Chamani, M.; Sadeghi, A.A.; Dadvar, P. Effect of in ovo feeding and dietary feeding of Silybum marianum extract on performance, immunity and blood cation anion balance of broiler chickens exposed to high temperatures. Iran. J. Appl. Anim. Sci. 2016, 6, 697–705.
    24. Gawel, A.; Kotonski, B.; Madej, J.; Mazurkiewicz, M. Effect of silimarin on chicken and turkey broilers’ rearing and the production indices of reproduction hen flocks. Med. Weter 2003, 59, 517–520.
    25. Tedesco, D.; Steidler, S.; Galletti, S.; Tameni, M.; Sonzogni, O.; Ravarotto, L. Efficacy of silymarin-phospholipid complex in reducing the toxicity of aflatoxin B1 in broiler chickens. Poult. Sci. 2004, 83, 1839–1843.
    26. Schönfeld, J.V.; Weisbrod, B.; Müller, M. Silibinin, a plant extract with antioxidant and membrane stabilizing properties, protects exocrine pancreas from cyclosporin A toxicity. Cell. Mol. Life Sci. 1997, 53, 917–920.
    27. Gažák, R.; Walterová, D.; Křen, V. Silybin and silymarin-new and emerging applications in medicine. Curr. Med. Chem. 2007, 14, 315–338.
    28. Chand, N.; Din Muhammad, F.R.; Durrani, M.; Sahibzada, S. Protective effects of milk thistle (Silybum marianum) against aflatoxin B1 in broiler chicks. Asian Austral. J. Anim. 2011, 24, 1011–1018.
    29. Makki, O.F.; Afzali, N.; Omidi, A. Effect of different levels of Silymarin (Silybum marianum) on growth rate, carcass variables and liver morphology of broiler chickens contaminated with aflatoxin B1. Poult. Sci. J. 2013, 1, 105–116.
    30. Harr, K.E. Clinical chemistry of companion avian species: A review. Vet. Clin. Pathol 2002, 31, 140–151.
    31. Wellington, K.; Jarvis, B. Silymarin: A review of its clinical properties in the management of hepatic disorder. BioDrugs 2001, 15, 465–489.
    32. Suchý, P.; Straková, E.; Kummer, V.; Herzig, I.; Písaříková, V.; Blechová, R.; Mašková, J. Hepatoprotective effects of milk thistle (Silybum marianum) seed cakes during the chicken broiler fattening. Acta Vet. Brno 2008, 77, 31–38.
    33. Alassi, S.B.; Allaw, A.A. Effect of adding of the milk thistle (Silybum marianum) seed powder in the traits of biochemical blood of the quail. Plant. Arch. 2020, 20, 962–964.
    34. Křížová, L.; Watzková, J.; Třináctý, J.; Richter, M.; Buchta, M. Rumen degradability and whole tract digestibility of flavonolignans from milk thistle (Silybum marianum) fruit expeller in dairy cows. Czech J. Anim. Sci. 2011, 56, 269–278.
    35. Šťastník, O.; Mrkvicová, E.; Pavlata, L.; Roztočilová, A.; Umlášková, B.; Anzenbacherová, E. Performance, biochemical profile and antioxidant activity of hens supplemented with addition of milk thistle (Silybum marianum) seed cakes in diet. Acta Univ. Agric. Silvc. Mendel. Brun. 2019, 67, 993–1003.